SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001256071-21-000003
Filing Date
2021-02-12
Accepted
2021-02-11 19:45:54
Documents
1

Document Format Files

Seq Description Document Type Size
1 Esperion11.txt SC 13G 1439
  Complete submission text file 0001256071-21-000003.txt   3169
Mailing Address C/O PLATINUM ASSET MANAGEMENT LEVEL 8, 7 MACQUARIE PLACE SYDNEY AUSTRALIA 2000 C3 00000
Business Address C/O PLATINUM ASSET MANAGEMENT LEVEL 8, 7 MACQUARIE PLACE SYDNEY AUSTRALIA 2000 C3 00000 61292557533
PLATINUM INVESTMENT MANAGEMENT LTD (Filed by) CIK: 0001256071 (see all company filings)

IRS No.: 000000000
Type: SC 13G

Mailing Address 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108
Business Address 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108 734-887-3903
Esperion Therapeutics, Inc. (Subject) CIK: 0001434868 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-87536 | Film No.: 21621883
SIC: 2834 Pharmaceutical Preparations